| Name | Company | Title | Industry | Location | Country | |
|---|---|---|---|---|---|---|
| inf*@contexttherapeutics.com | contexttherapeutics.com | |||||
| Andrew Tomaras | and***@forgetherapeutics.com | forgetherapeutics.com | Chief Scientific Officer | St. Louis, MO, US | ||
| Jamie Thorpe | jam**@forgetherapeutics.com | forgetherapeutics.com | Office Lead | San Diego, California, United States | ||
| inf*@forgetherapeutics.com | forgetherapeutics.com | |||||
| Steve Worland | swo*****@effector.com | eFFECTOR Therapeutics, Inc. | President and CEO | Biotechnology | Del Mar, CA, US | |
| Michael Byrnes | mby****@effector.com | eFFECTOR Therapeutics, Inc. | Chief Financial Officer | Biotechnology | California, United States | |
| Mark Densel | mde****@effector.com | eFFECTOR Therapeutics, Inc. | Vice President, Development Operations | Biotechnology | San Diego, CA, US | |
| Mayank Gandhi | mga****@effector.com | eFFECTOR Therapeutics, Inc. | Chief Business Officer | Biotechnology | California, United States | |
| Barbara Klencke | bkl*****@effector.com | eFFECTOR Therapeutics, Inc. | Chief Development Officer | Biotechnology | San Francisco, CA, US | |
| John O'Neil | jo'****@effector.com | eFFECTOR Therapeutics, Inc. | VP of Finance | Biotechnology | San Diego, CA, US |